We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+6.75%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$5.18B
AUM Growth
-$1.23B
Cap. Flow
-$1.43B
Cap. Flow %
-27.54%
Top 10 Hldgs %
16.5%
Holding
1,730
New
499
Increased
190
Reduced
247
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 1.97%
2 Technology 1.38%
3 Consumer Discretionary 0.99%
4 Communication Services 0.82%
5 Financials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBAY
626
PUT
DELISTED
Cymabay Therapeutics
CBAY
$1.05M 0.02%
120,000
+25,000
+26% +$200K
CLMT icon
627
CALL
Calumet Specialty Products
CLMT
$3.85B
$1.04M 0.02%
60,000
-40,000
-40% -$710K
KDNY
628
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.04M 0.02%
+45,000
New +$1.07M
DK icon
629
CALL
Delek US
DK
$4.16B
$1.03M 0.02%
45,000
+10,000
+29% +$250K
COOP
630
PUT
DELISTED
Mr. Cooper
COOP
$1.02M 0.02%
25,000
-272,000
-92% -$11.9M
ON icon
631
ON Semiconductor
ON
$31.8B
$1.02M 0.02%
12,424
-4,000
-24% -$304K
AMBP icon
632
CALL
Ardagh Metal Packaging
AMBP
$2.83B
$1.02M 0.02%
250,000
-500,000
-67% -$2.46M
STNG icon
633
Scorpio Tankers
STNG
$3.9B
$1.02M 0.02%
+18,100
New +$990K
AGNC icon
634
CALL
AGNC Investment
AGNC
$12.4B
$1.01M 0.02%
100,000
CGNT icon
635
Cognyte Software
CGNT
$659M
$1.01M 0.02%
+296,809
New +$1.07M
AKTS
636
PUT
DELISTED
Akoustis Technologies Inc
AKTS
$1M 0.02%
+325,000
New +$1.13M
FTAI icon
637
FTAI Aviation
FTAI
$21.1B
$999K 0.02%
35,714
+6,897
+24% +$163K
CPRX
638
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$995K 0.02%
+60,000
New +$990K
ABEV icon
639
Ambev
ABEV
$48.1B
$988K 0.02%
350,200
+277,800
+384% +$727K
AMRC icon
640
CALL
Ameresco
AMRC
$1.12B
$984K 0.02%
+20,000
New +$1.06M
AMRC icon
641
PUT
Ameresco
AMRC
$1.12B
$984K 0.02%
+20,000
New +$1.06M
RIG icon
642
Transocean
RIG
$5.89B
$983K 0.02%
+154,582
New +$993K
PVH icon
643
PVH
PVH
$4B
$981K 0.02%
+11,000
New +$897K
UPBD icon
644
PUT
Upbound Group
UPBD
$1.13B
$980K 0.02%
+40,000
New +$1.03M
IONS icon
645
Ionis Pharmaceuticals
IONS
$8.6B
$972K 0.02%
27,200
+14,200
+109% +$533K
VZIO
646
CALL
DELISTED
VIZIO Holding Corp.
VZIO
$968K 0.02%
105,500
+7,500
+8% +$67.7K
DICE
647
PUT
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$966K 0.02%
33,700
-2,300
-6% -$68.1K
ESI icon
648
CALL
Element Solutions
ESI
$8.95B
$966K 0.02%
+50,000
New +$986K
GOOS
649
PUT
Canada Goose Holdings
GOOS
$872M
$963K 0.02%
+50,000
New +$988K
GFF icon
650
CALL
Griffon
GFF
$3.95B
$960K 0.02%
30,000
+4,000
+15% +$146K

Similar funds

Caption Management's Q1 2023 Portfolio in Review

As of Q1 2023, Caption Management held 1,730 positions worth $5.18B, down 19% from $6.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management withdrew a net $1.43B in Q1 2023, closing 699 positions and reducing 247 holdings. Its most notable exit was PennyMac Mortgage Investment, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2% of assets, down from 2.5% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caption Management opened a new position in World Wrestling Entertainment worth $11.2M.

  • Caption Management's largest Q1 2023 buy was World Wrestling Entertainment: 123,000 shares worth $11.2M.
  • Caption Management added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $12.3M increase.
  • Caption Management's biggest Q1 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $13.3M.
  • Caption Management fully exited PennyMac Mortgage Investment in Q1 2023, selling an estimated $17.9M.
  • Caption Management's ten largest holdings make up 16% of its $5.18B portfolio in Q1 2023.
  • Caption Management opened 499 new positions and closed 699 in Q1 2023.
  • Caption Management's portfolio value fell 19% quarter-over-quarter to $5.18B.

Based on Caption Management's 13F filing for Q1 2023, filed 15 May 2023.